Product Datasheet
Retinoic Acid Receptor alpha Antibody
Catalog Number: 35355
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:P10276;
NCBI Gene#:5914
- Form of Antibody:
- Rabbit IgG in 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
- Immunogen:
- Recombinant fragment corresponding to a region within amino acids 156 and 433 of Retinoic Acid Receptor alpha.
- appl_detail:
- Western blotting: 1:500-1:3000
- other_names:
- NR1B1 antibody; RAR antibody; RARA antibody; RAR-alpha antibody; retinoic acid receptor alpha antibody; retinoic acid nuclear receptor alpha variant 1 antibody; nuclear receptor subfamily 1 group B member 1 antibody; nucleophosmin-retinoic acid receptor a
- Purification:
- Antibodies were purified by antigen-affinity chromatography.
- Specificity:
- The antibody detects endogenous levels of total Retinoic Acid Receptor alpha protein.
- Background:
- Retinoid signaling is transduced by 2 families of nuclear receptors, retinoic acid receptor (RAR) and retinoid X receptor (RXR; see MIM 180245), which form RXR/RAR heterodimers. In the absence of ligand, DNA-bound RXR/RARA represses transcription by recruiting the corepressors NCOR1 (MIM 600849), SMRT (NCOR2; MIM 600848), and histone deacetylase (see MIM 601241). When ligand binds to the complex, it induces a conformational change allowing the recruitment of coactivators, histone acetyltransferases (see MIM 603053), and the basic transcription machinery. Translocations that always involve rearrangement of the RARA gene are a cardinal feature of acute promyelocytic leukemia (APL; MIM 612376). The most frequent translocation is t(15,17)(q21;q22), which fuses the RARA gene with the PML gene (MIM 102578) (Vitoux et al., 2007 [PubMed 17468032]).[supplied by OMIM]
© Signalway Biotechnology All Rights Reserved.